Clinical Trial Update: Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a five-drug combination (etoposide, cyclophosphamide, thalidomide, celecoxib, and fenofibrate) in relapsed or progressive pediatric can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumor
• Leukemia
• Lymphoma
• Neuroblastoma
• Sarcoma
• Unspecified Childhood Solid Tumor

Drugs mentioned

• CELEBREX (Celecoxib)
• Cytoxan (cyclophosphamide)
• Thalomid (thalidomide)
• Tricor (fenofibrate)
• VePesid (etoposide)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Central Nervous System Tumor, Pediatric, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2014-09-09